Alan A Musso - Net Worth and Insider Trading
Alan A Musso Net Worth
The estimated net worth of Alan A Musso is at least $406 dollars as of 2024-11-05. Alan A Musso is the SVP, CFO & Treasurer of Catalyst Biosciences Inc and owns about 27 shares of Catalyst Biosciences Inc (CBIO) stock worth over $207. Alan A Musso is also the CFO and Treasurer of Bellicum Pharmaceuticals Inc and owns about 2,655 shares of Bellicum Pharmaceuticals Inc (BLCM) stock worth over $198. Details can be seen in Alan A Musso's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alan A Musso has not made any transactions after 2018-05-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alan A Musso
Alan A Musso Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alan A Musso owns 4 companies in total, including Bellicum Pharmaceuticals Inc (BLCM) , Catalyst Biosciences Inc (CBIO) , and Fulcrum Therapeutics Inc (FULC) among others .
Click here to see the complete history of Alan A Musso’s form 4 insider trades.
Insider Ownership Summary of Alan A Musso
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
BLCM | Bellicum Pharmaceuticals Inc | 2018-05-25 | CFO and Treasurer |
CBIO | Catalyst Biosciences Inc | 2011-06-07 | VP & CFO & Treasurer & Secretary |
FULC | Fulcrum Therapeutics Inc | 2023-08-07 | Chief Financial Officer |
2023-10-31 | director |
Alan A Musso Latest Holdings Summary
Alan A Musso currently owns a total of 2 stocks. Among these stocks, Alan A Musso owns 27 shares of Catalyst Biosciences Inc (CBIO) as of June 7, 2011, with a value of $207 and a weighting of 51.06%. Alan A Musso also owns 2,655 shares of Bellicum Pharmaceuticals Inc (BLCM) as of May 25, 2018, with a value of $198 and a weighting of 48.94%.
Latest Holdings of Alan A Musso
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CBIO | Catalyst Biosciences Inc | 2011-06-07 | 27 | 7.67 | 207 |
BLCM | Bellicum Pharmaceuticals Inc | 2018-05-25 | 2,655 | 0.07 | 198 |
Holding Weightings of Alan A Musso
Alan A Musso Form 4 Trading Tracker
According to the SEC Form 4 filings, Alan A Musso has made a total of 0 transactions in Catalyst Biosciences Inc (CBIO) over the past 5 years. The most-recent trade in Catalyst Biosciences Inc is the sale of 294 shares on June 7, 2011, which brought Alan A Musso around $673,075.
According to the SEC Form 4 filings, Alan A Musso has made a total of 0 transactions in Bellicum Pharmaceuticals Inc (BLCM) over the past 5 years. The most-recent trade in Bellicum Pharmaceuticals Inc is the sale of 621 shares on May 25, 2018, which brought Alan A Musso around $49,462.
Insider Trading History of Alan A Musso
- 1
Alan A Musso Trading Performance
Alan A Musso Ownership Network
Ownership Network List of Alan A Musso
Ownership Network Relation of Alan A Musso
Alan A Musso Owned Company Details
What does Bellicum Pharmaceuticals Inc do?
Who are the key executives at Bellicum Pharmaceuticals Inc?
Alan A Musso is the CFO and Treasurer of Bellicum Pharmaceuticals Inc. Other key executives at Bellicum Pharmaceuticals Inc include Chief Development Officer Charity Scripture , Principal Accounting Officer Charles S. Grass , and director & President and CEO Richard A. Fair .
Bellicum Pharmaceuticals Inc (BLCM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Bellicum Pharmaceuticals Inc (BLCM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bellicum Pharmaceuticals Inc (BLCM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Bellicum Pharmaceuticals Inc (BLCM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bellicum Pharmaceuticals Inc Insider Transactions
Alan A Musso Mailing Address
Above is the net worth, insider trading, and ownership report for Alan A Musso. You might contact Alan A Musso via mailing address: Fulcrum Therapeutics, Inc., 26 Landsdowne Street, Cambridge Ma 02139.